PANAPanacea Acquisition Corp. II

Nasdaq N/A


$ 10.24 $ -0.01 (-0.1 %)    

Monday, 17-Apr-2023 15:59:15 EDT
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 10.24
$ 10.51
$ -214,748.36 x 0
$ 0.00 x 0
$ 10.24 - $ 10.51
$ 9.69 - $ 10.92
114,368
na
241.1M
nm
$ 168.85
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-30-2023 12-31-2022 10-K
2 11-14-2022 09-30-2022 10-Q
3 08-15-2022 06-30-2022 10-Q
4 05-16-2022 03-31-2022 10-Q
5 03-31-2022 12-31-2021 10-K
6 11-12-2021 09-30-2021 10-Q
7 08-13-2021 06-30-2021 10-Q
8 06-14-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Last week saw continued momentum in special purpose acquisition company (SPAC) mergers, as KBL Merger (NASDAQ: KBLM), Acamar Pa...

 nuvation-bio-and-panacea-announce-business-combination-agreement-to-create-publicly-listed-oncology-drug-development-company

NEW YORK, Oct. 21, 2020 /PRNewswire/ -- Nuvation Bio Inc., a biopharmaceutical company focused on revolutionizing cancer treatm...